Omega-3 Fatty Acids and Thyroid Health: What the Research Actually Shows

Omega-3 fatty acids (EPA and DHA) have anti-inflammatory properties that may benefit people with Hashimoto's thyroiditis, and oily fish consumption has been linked to lower thyroid antibody levels. The evidence is promising but still early-stage — omega-3s appear to support a less inflammatory environment rather than directly treating the disease.

Why omega-3s matter for thyroid health

Hashimoto's thyroiditis is an autoimmune condition driven by chronic, low-grade inflammation. The immune system mistakenly attacks thyroid tissue, and inflammatory signaling molecules called cytokines — particularly TNF-α, IL-1β, and IL-6 — help sustain that attack over time. Anything that dampens that inflammatory backdrop without suppressing immune function broadly is worth understanding.

That's where omega-3 fatty acids enter the picture. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain polyunsaturated fats found primarily in fatty fish. Once consumed, they're incorporated into cell membranes throughout the body, including immune cells, where they act as raw material for a class of compounds called resolvins and protectins [C5].

Resolvins — literally named for their role in "resolving" inflammation — actively signal immune cells to stand down after an inflammatory response. EPA-derived resolvins (the E series) and DHA-derived resolvins (the D series) both inhibit pro-inflammatory cytokines and chemokines [C5]. In people with Hashimoto's, serum concentrations of resolvin D1 have been found to be significantly lower than in healthy controls [C6]. This deficit may mean the resolution process is impaired, allowing inflammation to persist longer than it should.

There's also a plausible thyroid-specific angle: thyroid hormone itself appears to enhance the production of DHA-derived resolvins in the liver, suggesting a synergistic relationship between adequate thyroid hormone and omega-3 status [C2].

What the research actually shows

The most rigorous evidence for omega-3s and autoimmune disease comes from the VITAL trial — a large, randomized, placebo-controlled study of 25,871 older US adults who took either omega-3 supplements (1,000 mg/day), vitamin D, both, or placebo for five years [C1]. The results showed that omega-3 supplementation alone reduced incident autoimmune disease by about 15%, though this fell just short of statistical significance. When omega-3s were combined with vitamin D, the reduction in autoimmune disease was more pronounced and statistically meaningful [C1]. The authors concluded that both nutrients together appear protective against new autoimmune diagnoses.

More directly relevant to thyroid autoimmunity: a prospective Italian study compared thyroid antibody levels in four groups of pregnant and postpartum women based on what kind of fish they regularly ate [C3]. Women who regularly consumed oily fish (sardines, mackerel, anchovies — all high in omega-3s) had the lowest rates of thyroid antibody positivity and the lowest antibody concentrations. By contrast, women who primarily ate swordfish — a large predatory fish that accumulates mercury — had the highest antibody levels [C3]. The study can't prove causation from omega-3s alone (oily fish eaters may have other healthy habits), but the biological plausibility is supported by the mechanism work.

A 2022 review specifically examined resolvins in Hashimoto's disease and found that patients had measurably lower resolvin levels than controls, and that supplementing with EPA/DHA raised those levels [C6]. A 2024 network meta-analysis on supplements for Hashimoto's found omega-3s showed a favorable signal for reducing inflammatory markers, though the evidence base remains smaller than for selenium [C7].

What omega-3s have not clearly demonstrated is a direct, consistent reduction in TPO antibody titers specifically — the marker most commonly tracked in Hashimoto's management. Selenium has a stronger evidence base for that outcome. The omega-3 story is more about the inflammatory environment than the autoimmune assault itself.

Where the evidence is weaker

Most omega-3 studies in thyroid disease have been observational or short-term, with small sample sizes. The VITAL trial wasn't designed to specifically test Hashimoto's — it looked at incident autoimmune disease broadly in older adults, so the findings may not translate directly to someone already living with an autoimmune thyroid condition [C1].

Dosing is also an open question. The fish consumption studies used dietary intake as a proxy, not standardized supplement doses. The VITAL trial used 1,000 mg/day of combined EPA+DHA — a relatively modest dose — and the omega-3 arm alone didn't reach statistical significance [C1].

Mercury contamination in large predatory fish (tuna, swordfish, shark) is a real confound in fish-consumption studies. Some of what looks like a benefit from oily fish may partly reflect harm from the mercury-laden fish people are eating less of [C2].

Finally, omega-3 supplements can have mild blood-thinning effects at high doses and may interact with anticoagulant medications. Anyone taking blood thinners should discuss supplementation with their doctor before starting.

Practical guidelines

1. Prioritize food sources over supplements when possible. Fatty fish like salmon, mackerel, sardines, and anchovies provide EPA and DHA alongside other nutrients (vitamin D, selenium, protein) that matter for thyroid health [C4]. Aim for two to three servings per week of small oily fish, which carry far lower mercury risk than large predatory species [C2].

2. If you supplement, a standard dose of 1–2 g EPA+DHA/day is a reasonable starting point. This aligns with the dose used in the VITAL trial and is within the FDA's safe upper limit of 5 g/day from supplements [C4]. Look for products that have been third-party tested for purity.

3. Plant-based omega-3s (ALA from walnuts, flaxseed, chia seeds) are beneficial but don't substitute for EPA/DHA. The conversion of ALA to EPA and DHA in the body is inefficient — typically under 10% [C4]. If you're vegetarian or vegan, algae-derived DHA/EPA supplements bypass that conversion problem entirely.

4. Don't expect omega-3s to lower your antibodies dramatically. If that's your goal, the research points more strongly to selenium as the nutrient to discuss with your doctor. Omega-3s are better framed as a way to support an overall anti-inflammatory diet pattern.

Frequently asked questions

Will fish oil lower my TPO antibodies? Possibly, but the evidence isn't strong enough to say yes with confidence. Some studies show reduced inflammatory markers with omega-3 supplementation, but consistent TPO antibody reductions haven't been demonstrated the way they have with selenium [C7]. Think of fish oil as one piece of an anti-inflammatory diet, not a targeted antibody-lowering therapy.

How long would I need to take omega-3s to see any effect? The VITAL trial ran for five years [C1]. Most dietary intervention studies in thyroid disease run three to six months and show modest results. This is a long-game strategy, not a quick fix.

Is it safe to take fish oil if I'm on levothyroxine? Generally yes, though take them at a different time of day than your medication. Anything taken close to levothyroxine can theoretically affect absorption. A two-hour gap is a reasonable precaution. Always check with your prescriber if you're on anticoagulants.

What about krill oil? Krill oil contains EPA and DHA in phospholipid form, which some research suggests is absorbed more efficiently. However, the evidence base for krill oil specifically in thyroid conditions is thin. Either form is probably fine; cost and sustainability are reasonable tie-breakers.

Bottom line

Omega-3 fatty acids — particularly EPA and DHA from oily fish — have meaningful anti-inflammatory properties and may support a healthier immune environment in Hashimoto's thyroiditis [C5]. The VITAL trial showed a directional (though not statistically significant) reduction in incident autoimmune disease with omega-3 supplementation [C1], and dietary studies find associations between oily fish intake and lower thyroid antibody levels [C3]. The evidence doesn't yet support calling omega-3s a treatment, but they're a reasonable, low-risk addition to a thyroid-supportive diet — especially if your current diet is low in fatty fish [C4].

Sources

1. [C1] Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. PubMed: 35082139

2. [C2] Benvenga S, Famà F, Perdichizzi LG, et al. Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids. Front Endocrinol. 2022;13:891233. PubMed: 35712237

3. [C3] Benvenga S, Vigo MT, Metro D, et al. Type of fish consumed and thyroid autoimmunity in pregnancy and postpartum. Endocrine. 2016;52(1):120-9. PubMed: 26306774

4. [C4] NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Health Professional Fact Sheet. Updated 2023. ods.od.nih.gov

5. [C5] Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645-62. PMC: 3575932

6. [C6] Benvenga S, et al. The Significance and Process of Inflammation Involving Eicosapentaenoic and Docosahexaenoic Derivatives in Hashimoto's Disease. Nutrients. 2025;17(10):1715. mdpi.com

7. [C7] Zhao Y, et al. Effects of different supplements on Hashimoto's thyroiditis: a systematic review and network meta-analysis. Front Endocrinol. 2024;15:1445878. frontiersin.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.